Karl S. Theil

4.9k citations

73 papers · 3.6k indexed · 1 hit paper · h-index 27

Hematology top 0.2%
- Acute Myeloid Leukemia Research 28
- Chronic Myeloid Leukemia Treatments 11
- Hematopoietic Stem Cell Transplantation 6
Genetics top 1%
- Chronic Lymphocytic Leukemia Research 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
Public Health, Environmental and Occupational Health top 2%
- Acute Lymphoblastic Leukemia research 16
Cancer Research top 10%
Molecular Biology top 10%
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 8
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 5

Co-authors: Anwar N. Mohamed Kenneth J. Kopecky Frederick R. Appelbaum Marilyn L. Slovak David R. Head Stephen J. Forman Peter A. Cassileth Cheryl L. Willman
Cited by: Hematology Genetics Public Health, Environmental and Occupational Health
Journals: Proceedings of the National Academy of Sciences (3 papers)Journal of Clinical Oncology (1 paper)Blood (12 papers)
Partner nations: United States South Korea Switzerland

In The Last Decade

Karl S. Theil

72 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Karl S. Theil

Since Specialization

Citations

This map shows the geographic impact of Karl S. Theil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl S. Theil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl S. Theil more than expected).

Fields of papers citing papers by Karl S. Theil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl S. Theil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl S. Theil. The network helps show where Karl S. Theil may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karl S. Theil, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karl S. Theil Line = papers co-authored together Karl S. Theil links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Utility of Bruton’s Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström’s Macroglobulinemia) Advances in Hematology ·Maroun Bou Zerdan,Jason Valent,Maria Julia Diacovo,Karl S. Theil,Chakra P. Chaulagain	2022	6
2	Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations Journal of Clinical Pathology ·Samir Turakhia,Gurunathan Murugesan,Claudiu Cotta,Karl S. Theil	2016	5
3	The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors Cancer Genetics ·Karl S. Theil,Claudiu Cotta	2014	2
4	Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities Blood ·Samar Farha,Kewal Asosingh,Weiling Xu,Jacqueline Sharp,Deepa George,Suzy Comhair,Margaret Park,W.H. Wilson Tang,James E. Loyd,Karl S. Theil,Raymond Tubbs,Eric D. Hsi,Alan Lichtin,Serpil C. Erzurum	2011	107
5	Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis Molecular Cytogenetics ·Kathryn A. Kolquist,Roger A. Schultz,Marilyn L. Slovak,Lisa D. McDaniel,Theresa C. Brown,Raymond R. Tubbs,James R. Cook,Karl S. Theil,Victoria Cawich,Caitlin Valentin,Sara L. Minier,Nicholas J. Neill,Steve Byerly,S. Annie Morton,Trilochan Sahoo,Blake C. Ballif,Lisa G. Shaffer	2011	10
6	College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis Genetics in Medicine ·Arthur R. Brothman,Michelle Dolan,Barbara K. Goodman,Jonathan P. Park,Diane L. Persons,Debra Saxe,James Tepperberg,Karen D. Tsuchiya,Daniel L. Van Dyke,Kathleen Wilson,Daynna J. Wolff,Karl S. Theil	2011	12
7	FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q) Leukemia Research ·Hideki Makishima,Manjot Rataul,Lukasz P. Gondek,Jungwon Huh,James R. Cook,Karl S. Theil,Mikkael A. Sekeres,Elizabeth Kuczkowski,Christine L. O’Keefe,Jaroslaw P. Maciejewski	2009	53
8	A rare trigger for macrophage activation syndrome Rheumatology International ·Shikhar Agarwal,Jayavani Moodley,Gati Goel,Karl S. Theil,Syed Mahmood,Richard Lang	2009	24
9	Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation Bone Marrow Transplantation ·Ronald Sobecks,Edward J. Ball,Medhat Askar,Karl S. Theil,Lisa Rybicki,Dawn Thomas,Stacey Brown,M Kalaycio,Steve Andresen,Brad Pohlman,Robert M. Dean,John Sweetenham,Roger M. Macklis,Laura Bernhard,Kelly Cherni,Edward A. Copelan,J. Maciejewski,Brian J. Bolwell	2008	13
10	400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation Bone Marrow Transplantation ·Ronald Sobecks,Robert M. Dean,Lisa Rybicki,Jonathan Chan,Karl S. Theil,Roger M. Macklis,Steve Andresen,M Kalaycio,Brad Pohlman,Christina Ferraro,Kelly Cherni,John Sweetenham,Edward A. Copelan,Brian J. Bolwell	2008	7
11	Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia Leukemia & lymphoma ·Anjali S. Advani,Tao Jin,Giridharan Ramsingh,Ramón V. Tiu,Wael Saber,Karl S. Theil,Ronald Sobecks,Mikkael A. Sekeres,Ed Copelan,Shawnda Sungren,Barbara Tripp,Matt Kalaycio	2008	4
12	High-Resolution Genomic Arrays Facilitate Detection of Novel Cryptic Chromosomal Lesions in Myelodysplastic Syndromes Experimental Hematology ·Christine L. O’Keefe,Ramón V. Tiu,Lukasz P. Gondek,Jennifer Powers,Karl S. Theil,Matt Kalaycio,Alan Lichtin,Mikkael A. Sekeres,Jaroslaw P. Maciejewski	2007	24
13	Frequencies and characterization of cytogenetically unrelated clones in various hematologic malignancies: seven years of experiences in a single institution Cancer Genetics and Cytogenetics ·Jin‐Yeong Han,Karl S. Theil,Gerald A. Hoeltge	2006	13
14	Efficient identification of T‐cell clones associated with graft‐versus‐host disease in target tissue allows for subsequent detection in peripheral blood British Journal of Haematology ·Rose Beck,Marcin W. Włodarski,Lukasz P. Gondek,Karl S. Theil,Ralph J. Tuthill,Ronald Sobeck,Brian J. Bolwell,Jaroslaw P. Maciejewski	2005	21
15	Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone Bone Marrow Transplantation ·Brian J. Bolwell,Ronald Sobecks,Brad Pohlman,Steve Andresen,Karl S. Theil,Sheila Serafino,Lisa Rybicki,M Kalaycio	2003	6
16	Detection of Mature T-Cell Leukemias by Flow Cytometry Using Anti-T-Cell Receptor V b Antibodies American Journal of Clinical Pathology ·Rose Beck,Steve Stahl,Christine L. O’Keefe,Jaroslaw P. Maciejewski,Karl S. Theil,Eric D. Hsi	2003	46
17	Localization of FCGR1 encoding Fcγ receptor class I in primates: molecular evidence for two pericentric inversions during the evolution of human chromosome 1 Cytogenetic and Genome Research ·(unknown),L.E. Blue,L.L. Culley,Robert P. Kimberly,Clark L. Anderson,Karl S. Theil	1998	17
18	The three genes of the human FCGR1 gene family encoding FcγRI flank the centromere of chromosome 1 at 1p12 and 1q21 Cytogenetic and Genome Research ·(unknown),Emily Chang,Karl S. Theil,Uta Francke,Clark L. Anderson	1996	28
19	Characterization of the 5q‐ breakpoint in an acute nonlymphocytic leukemia patient using pulsed‐field gel electrophoresis American Journal of Medical Genetics ·Donald Thornton,Karl S. Theil,Robert A. Payson,Stanley P. Balcerzak,Ing‐Ming Chiu	1991	7
20	Hairy Cell Leukemia Involving an Inguinal Hernial Sac Acta Haematologica ·Mark J. Melaragno,Karl S. Theil,W. Marsh,Daniel D. Sedmak,Bertha A. Bouroncle	1990	8

About Karl S. Theil

Karl S. Theil is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 73 papers that have together received 3.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (28 papers), Acute Lymphoblastic Leukemia research (16 papers), Chronic Myeloid Leukemia Treatments (11 papers), Chronic Lymphocytic Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Hematology (2.3k citations), Genetics (903 citations) and Public Health, Environmental and Occupational Health (798 citations). Karl S. Theil has collaborated with scholars based in United States, South Korea and Switzerland. Frequent co-authors include Anwar N. Mohamed, Kenneth J. Kopecky, Frederick R. Appelbaum, Marilyn L. Slovak, David R. Head, Stephen J. Forman, Peter A. Cassileth, Cheryl L. Willman, Jacob M. Rowe and David H. Harrington. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact